BB Biotech AG Working Capital to Net Assets Ratio
BB Biotech AG working capital to net assets ratio. BB Biotech AG (BION) has a Working Capital to Net Assets ratio of 100.0% as of September 2025. Working capital of CHF2.31 Billion (current assets of CHF2.31 Billion minus current liabilities of CHF3.66 Million) is measured against net assets of CHF2.31 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. Check BB Biotech AG (BION) tangible net worth to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of BB Biotech AG (2012–2024)
Working capital to net assets ratio of BB Biotech AG from 2012 to 2024. This chart shows how BB Biotech AG's Working Capital to Net Assets ratio has evolved across 13 annual periods from 2012 to 2024. As of September 2025, the ratio stands at 100.0%, reflecting working capital of CHF2.31 Billion against net assets of CHF2.31 Billion CHF. See BB Biotech AG defensive interval ratio to measure how many days the company can operate on defensive assets alone.
BB Biotech AG Working Capital to Net Assets Ratio by Year (2012–2024)
BB Biotech AG working capital to net assets ratio by year from 2012 to 2024. The table below presents the year-by-year Working Capital to Net Assets ratio for BB Biotech AG from 2012 to 2024, covering 13 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see BB Biotech AG asset portfolio.
| Year | WC/NA Ratio | Working Capital (CHF) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 100.0% | CHF2.29 Billion | CHF2.29 Billion | CHF2.41 Billion | CHF121.11 Million | ▼ -12.8 pp |
| 2023 | 112.8% | CHF2.62 Billion | CHF2.32 Billion | CHF2.64 Billion | CHF16.66 Million | ▲ +126.4 pp |
| 2022 | -13.6% | CHF-365.31 Million | CHF2.69 Billion | CHF1.95 Million | CHF367.25 Million | ▼ -2.7 pp |
| 2021 | -10.9% | CHF-357.75 Million | CHF3.29 Billion | CHF2.83 Million | CHF360.59 Million | ▼ -110.6 pp |
| 2020 | 99.7% | CHF3.89 Billion | CHF3.90 Billion | CHF3.96 Billion | CHF75.59 Million | ▲ +98.9 pp |
| 2019 | 0.8% | CHF27.16 Million | CHF3.39 Billion | CHF30.71 Million | CHF3.54 Million | ▲ +0.1 pp |
| 2018 | 0.7% | CHF19.18 Million | CHF2.88 Billion | CHF22.41 Million | CHF3.22 Million | ▲ +0.5 pp |
| 2017 | 0.2% | CHF7.24 Million | CHF3.54 Billion | CHF10.73 Million | CHF3.49 Million | ▼ -0.4 pp |
| 2016 | 0.6% | CHF17.50 Million | CHF3.00 Billion | CHF20.38 Million | CHF2.88 Million | ▲ +0.0 pp |
| 2015 | 0.5% | CHF21.68 Million | CHF3.98 Billion | CHF25.04 Million | CHF3.35 Million | ▲ +0.4 pp |
| 2014 | 0.2% | CHF6.29 Million | CHF3.49 Billion | CHF8.97 Million | CHF2.68 Million | ▼ -1.9 pp |
| 2013 | 2.1% | CHF43.56 Million | CHF2.12 Billion | CHF43.70 Million | CHF134.00K | ▲ +0.5 pp |
| 2012 | 1.5% | CHF18.71 Million | CHF1.23 Billion | CHF18.86 Million | CHF151.00K | — |